| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $901.3M | +15.2% |
| Cost of Revenue | $501.2M | +28.3% |
| Gross Profit | $400.1M | +2.2% |
| R&D Expense | $145.0M | +37.5% |
| SG&A Expense | $68.8M | -1.3% |
| Operating Income | $109.4M | -27.5% |
| Pre-tax Income | $135.2M | -18.7% |
| Income Tax | $13.3M | -62.0% |
| Net Income | $94.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $757.4M | +85.9% |
| Short-term Investments | $35.5M | +83.4% |
| Accounts Receivable | $504.3M | +30.3% |
| Inventory | $702.6M | +17.5% |
| Current Assets | $2.44B | +64.3% |
| Total Assets | $2.87B | +54.8% |
| Current Liabilities | $745.7M | +16.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.3M | -106.8% |
| Capital Expenditures | $56.3M | -31.7% |
| Investing Cash Flow | -$390.3M | -3163.9% |
| Financing Cash Flow | $742.5M | +702.9% |
| Free Cash Flow | -$66.6M | -195.2% |
| -9.2% |
| EPS (Basic) | $1.47 | -12.0% |
| EPS (Diluted) | $1.37 | -10.5% |
| Long-term Debt |
| $214.0M |
| +42.7% |
| Total Liabilities | $941.7M | +23.9% |
| Stockholders' Equity | $1.46B | +61.9% |